IN8bio, Inc. (INAB)
1.87
+0.07
(+3.89%)
USD |
NASDAQ |
May 29, 16:00
1.81
-0.06
(-3.21%)
After-Hours: 20:00
IN8bio Total Assets (Quarterly) : 26.26M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Calidi Biotherapeutics, Inc. | 9.591M |
| Connect Biopharma Holdings Ltd. | 60.07M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.484M |
| Shareholders Equity (Quarterly) | 22.78M |
| Debt to Equity Ratio | 0.1033 |
| Current Ratio | 10.50 |
| Net Debt Paydown Yield | 7.97% |